The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery

Completed · Phase 4

Conditions studied: Blood Loss

In brief

The purpose of this study is to determine if the agent, Floseal, can decrease the amount of blood patients lose after total knee replacement (TKR) surgery. If this product can be found to have an effect on bleeding, it may potentially reduce the problems associated with bleeding after knee replacement surgery such as pain, stiffness, and the need to have a blood transfusion. The subject's overall participation will be over a period of 6 weeks.

Key facts

Study ID

NCT00990288

Run by

Hospital for Special Surgery, New York

People needed

196

Starts

2007-10-01

Expected to finish

2010-08-01

Last updated by the study team

2017-12-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Single Knee replacement for arthritis of the knee

You may not qualify if…

• No inflammatory arthritis (ie. Rheumatoid arthritis)
• No allergies to cow meat (bovine allergies
• No history of bleeding disorders

Where it is running

• Hospital for Special Surgery — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.